RecruitingNCT05242055

Integrated Diagnosis and Treatment of CKD on Outcomes

A Prospective, Cohort, and Observational Study of the Effect of Integrated Diagnosis and Treatment of Chronic Kidney Disease (CKD) on Clinical Outcomes in Real World Clinical Practice


Sponsor

Capital Medical University

Enrollment

1,000 participants

Start Date

Feb 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Objective: To establish a study cohort and follow up of patients with CKD in our hospital, and evaluate the status of integrated CKD diagnosis and treatment according to guidelines in the real world, as well as the clinical prognosis of patients with different stratification. Methods: By establishing a cohort of 1000 patients with CKD and conducting long-term follow-up, integrated diagnosis and treatment for CKD was performed, namely: Regular monitoring, control of blood pressure, blood glucose, blood lipid, correction of anemia, minerals - bone metabolic abnormalities, malnutrition, acid and alkali, and electrolyte disorder, diet and exercise, such as the guidance of integrated management, non intrusive, observational studies, prospective cohort were analyzed retrospectively, describe the implementation of the integration of diagnosis and treatment, chronic kidney disease (CKD) Stratified analysis and risk factor analysis were performed for cardiovascular disease and other main endpoint events, so as to objectively reflect the status of integrated treatment of CKD and provide data support for continuous quality improvement of CKD diagnosis and treatment and improvement of clinical prognosis of patients.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study tests an integrated care model — where kidney disease (CKD) is diagnosed and managed together as one coordinated system — to see whether this approach leads to better outcomes than current fragmented care for people at risk of developing CKD. **You may be eligible if...** - You are 18 or older - You are estimated to be at risk of developing chronic kidney disease (CKD) - You are expected to be available for at least 6 months of follow-up - You are willing to sign an informed consent form **You may NOT be eligible if...** - You are under 18 or 100 years or older - You are unable to comply with the study procedures - Your estimated follow-up time is 6 months or less Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIntegrated diagnosis and treatment for CKD

This is an observational study. Investor will not intervene the clinical practice of doctors. In the real world, there would be many factors affect the proceeding of the guidelines contents. There will be integrated diagnosis and treatment during follow-up.


Locations(1)

Nephrology Department of Beijing Jishuitan Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05242055


Related Trials